Yang, Kang
Yue, Baosen
Tian, Huan
Wang, Lu
Yang, Xiao
Zhang, Weiying
Funding for this research was provided by:
Open Project of Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research (KF2201)
Xi’an Science and Technology Bureau (23YXYJ0042)
Article History
Received: 27 November 2024
Accepted: 24 March 2025
First Online: 7 April 2025
Declarations
:
: This study was approved by the Ethics Committee of MDKN Biotechnology Co., Lt. All animal experiments were performed in accordance with the ARRIVE guidelines. All methods were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.